TXG

10x Genomics, Inc. Class A Common Stock

16.31

USD

TXG Earnings Reports

Positive Surprise Ratio

TXG beat 13 of 25 last estimates.

52%

Next Report

Date of Next Report

Jan 12, 2026

Estimate for Q4 25 (Revenue/ EPS)

$157.54M

-$0.22

Implied change from Q3 25 (Revenue/ EPS)

+5.73%

Implied change from Q4 24 (Revenue/ EPS)

-4.54%

-45.00%

10x Genomics, Inc. Class A Common Stock earnings per share and revenue

On Nov 06, 2025, TXG reported earnings of -0.22 USD per share (EPS) for Q3 25, beating the estimate of -0.29 USD, resulting in a 24.40% surprise. Revenue reached 149.00 million, compared to an expected 143.91 million, with a 3.54% difference. The market reacted with a +17.31% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 18 analysts forecast an EPS of -0.22 USD, with revenue projected to reach 157.54 million USD, implying an increase of 0.00% EPS, and increase of 5.73% in Revenue from the last quarter.

FAQ

What were 10x Genomics, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, 10x Genomics, Inc. Class A Common Stock reported EPS of -$0.22, beating estimates by 24.4%, and revenue of $149.00M, 3.54% above expectations.

How did the market react to 10x Genomics, Inc. Class A Common Stock's Q3 2025 earnings?

The stock price moved up 17.31%, changed from $13.00 before the earnings release to $15.25 the day after.

When is 10x Genomics, Inc. Class A Common Stock expected to report next?

The next earning report is scheduled for Jan 12, 2026.

What are the forecasts for 10x Genomics, Inc. Class A Common Stock's next earnings report?

Based on 18 analysts, 10x Genomics, Inc. Class A Common Stock is expected to report EPS of -$0.22 and revenue of $157.54M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.